In recent years, considerable attention has been directed towards programmed death ligand 1 (PD-L1) due to its significant role in maintaining an immunosuppressive tumour microenvironment by negatively modulating anti-tumour responses, leading to anergy or the exhaustion of programmed death receptor 1 (PD-1)-expressing T cells [43]. The gene discussed is CD274; the disease is neoplasm.